Sequenom

About:

Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.

Website: https://womenshealth.labcorp.com

Twitter/X: sequenomlabs

Top Investors: National Institutes of Health

Description:

Sequenom offers genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders. The company provides a nucleic acid analysis platform that measures genetic target material and variations.

Total Funding Amount:

$185M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

San Diego, California, United States

Founded Date:

1994-01-01

Contact Email:

info(AT)sequenom.com

Founders:

Charles Cantor, Hubert Koster

Number of Employees:

501-1000

Last Funding Date:

2012-09-24

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai